Anti-IL-17A (Taltz) (Ixekizumab biosimilar) mAb
Gecertificeerd

Anti-IL-17A (Taltz) (Ixekizumab biosimilar) mAb

Catalog #: 12-2002-100
Maat: 100 µg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Description

Ixekizumab/ Anti-IL-17A (Taltz) is a humanized IgG4 biosimilar monoclonal antibody expressed by mammalian cell lines that block the biological activity of IL-17A. IL-17A is a pro-inflammatory cytokine that triggers immune cells like neutrophils, lymphocytes, macrophages, monocytes, natural killer (NK) cells, and B cells that play essential roles in innate and adaptive immune responses. IL-17A binds IL17RA-IL17RC heterodimeric receptor complex to activate TRAF6 and NF-kappaB pathway, leading to pro inflammatory cytokines and chemokines gene expression. The Ixekizumab biosimilar developed by Abeomics is a high-quality research grade biosimilar and is not to be used for therapeutic or diagnostic procedures for humans and animals.

Host

• Humanized

Reactivity

Human

Clonality

• Monoclonal

Applications

ELISA

Purification

Purified from cell culture supernatant by affinity chromatography

Storage Conditions

Store at -20°C to -80°C (Avoid repeated freezing and thawing) .

Applications Notes

ELISA 1:5000-10000, FACS 1:100

Isotype

IgG4

Beschrijving

Ixekizumab/ Anti-IL-17A (Taltz) is a humanized IgG4 biosimilar monoclonal antibody expressed by mammalian cell lines that block the biological activity of IL-17

Specificaties

ProductnaamAnti-IL-17A (Taltz) (Ixekizumab biosimilar) mAb
Categorie
Beschikbare grootte100 µg
Catalogusnummer12-2002-100